- Home
- ALKS vs HHH Comparison
ALKS vs HHH Comparison
Compare ALKS & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- HHH
- Stock Information
- Founded
- ALKS 1987
- HHH 2010
- Country
- ALKS Ireland
- HHH United States
- Employees
- ALKS N/A
- HHH N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- ALKS Health Care
- HHH Real Estate
- Exchange
- ALKS Nasdaq
- HHH Nasdaq
- Market Cap
- ALKS 4.7B
- HHH 3.9B
- IPO Year
- ALKS 1991
- HHH N/A
- Fundamental
- Price
- ALKS $30.10
- HHH $76.30
- Analyst Decision
- ALKS Buy
- HHH Strong Buy
- Analyst Count
- ALKS 11
- HHH 2
- Target Price
- ALKS $36.00
- HHH $82.00
- AVG Volume (30 Days)
- ALKS 1.3M
- HHH 351.0K
- Earning Date
- ALKS 02-13-2025
- HHH 02-26-2025
- Dividend Yield
- ALKS N/A
- HHH N/A
- EPS Growth
- ALKS 55.25
- HHH N/A
- EPS
- ALKS 1.97
- HHH 1.52
- Revenue
- ALKS $1,505,121,000.00
- HHH $1,195,412,000.00
- Revenue This Year
- ALKS N/A
- HHH $65.32
- Revenue Next Year
- ALKS N/A
- HHH N/A
- P/E Ratio
- ALKS $15.28
- HHH $50.07
- Revenue Growth
- ALKS N/A
- HHH 10.91
- 52 Week Low
- ALKS $22.90
- HHH $56.24
- 52 Week High
- ALKS $32.88
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- ALKS 59.48
- HHH 45.13
- Support Level
- ALKS $28.28
- HHH $71.49
- Resistance Level
- ALKS $29.36
- HHH $81.00
- Average True Range (ATR)
- ALKS 0.69
- HHH 2.00
- MACD
- ALKS 0.12
- HHH 0.33
- Stochastic Oscillator
- ALKS 97.96
- HHH 50.58
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments, and Seaport.